MarketBeat
Collegium Pharmaceutical to Buy AZSTARYS for $650M, Expanding ADHD Franchise Through 2037
📈
AI Sentiment
Highly Positive
9/10
Collegium Pharmaceutical Inc. News
Latest updates and market news for COLL
3 news
Mar 18 - Mar 24, 2026
Page 1
MT Newswires
Collegium Pharmaceutical to Acquire Azstarys from Corium Therapeutics for $650 Million in Cash
âž–
AI Sentiment
Neutral
5/10
GlobeNewswire
Collegium to Acquire AZSTARYS® from Corium Therapeutics, Strengthening Position in ADHD and Accelerating Growth Trajectory
📈
AI Sentiment
Highly Positive
9/10
Share this news page